Molecular magnetic resonance imaging in cardiovascular medicine

被引：106

作者：

Sosnovik, David E.

Nahrendorf, Matthias

Weissleder, Ralph

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res, Charlestown, MA 02129 USA

[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Cardiol, Charlestown, MA 02129 USA

来源：

CIRCULATION | 2007年 / 115卷 / 15期

关键词：

atherosclerosis; cardiovascular diseases; magnetic resonance imaging; myocardium; nanotechnology;

D O I：

10.1161/CIRCULATIONAHA.106.658930

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2076 / 2086

页数：11

共 84 条

[1] Tunable imaging of cells labeled with MRI-PARACEST agents [J].

Aime, S ;

Carrera, C ;

Delli Castelli, D ;

Crich, SG ;

Terreno, E .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (12) :1813-1815

[2] Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin [J].

Atanasijevic, Tatjana ;

Shusteff, Maxim ;

Fam, Peter ;

Jasanoff, Alan .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (40) :14707-14712

[3] Detection of atherosclerotic plaque with gadofluorine-enhanced magnetic resonance imaging [J].

Barkhausen, J ;

Ebert, W ;

Heyer, C ;

Debatin, JF ;

Weinmann, HJ .

CIRCULATION, 2003, 108 (05) :605-609

[4] In vivo detection and imaging of phosphatidylserine expression during programmed cell death [J].

Blankenberg, FG ;

Katsikis, PD ;

Tait, JF ;

Davis, RE ;

Naumovski, L ;

Ohtsuki, K ;

Kopiwoda, S ;

Abrams, MJ ;

Darkes, M ;

Robbins, RC ;

Maecker, HT ;

Strauss, HW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6349-6354

[5] Oligomerization of Paramagnetic Substrates Result in Signal Amplification and can be Used for MR Imaging of Molecular Targets [J].

Bogdanov, Alexei, Jr. ;

Matuszewski, Lars ;

Bremer, Christoph ;

Petrovsky, Alexander ;

Weissleder, Ralph .

MOLECULAR IMAGING, 2002, 1 (01) :16-23

[6] In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent [J].

Botnar, RM ;

Perez, AS ;

Witte, S ;

Wiethoff, AJ ;

Laredo, J ;

Hamilton, J ;

Quist, W ;

Parsons, EC ;

Vaidya, A ;

Kolodziej, A ;

Barrett, JA ;

Graham, PB ;

Weisskoff, RM ;

Manning, WJ ;

Johnstone, MT .

CIRCULATION, 2004, 109 (16) :2023-2029

[7] The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates [J].

Caravan, P ;

Cloutier, NJ ;

Greenfield, MT ;

McDermid, SA ;

Dunham, SU ;

Bulte, JWM ;

Amedio, JC ;

Looby, RJ ;

Supkowski, RM ;

Horrocks, WD ;

McMurry, TJ ;

Lauffer, RB .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (12) :3152-3162

[8] In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla [J].

Caruthers, SD ;

Neubauer, AM ;

Hockett, FD ;

Lamerichs, R ;

Winter, PM ;

Scott, MJ ;

Gaffney, PJ ;

Wickline, SA ;

Lanza, GM .

INVESTIGATIVE RADIOLOGY, 2006, 41 (03) :305-312

[9] Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates [J].

Chen, John W. ;

Sans, Manel Querol ;

Bogdanov, Alexei, Jr. ;

Weissleder, Ralph .

RADIOLOGY, 2006, 240 (02) :473-481

[10] Human myeloperoxidase: A potential target for molecular MR imaging in atherosclerosis [J].

Chen, JW ;

Pham, W ;

Weissleder, R ;

Bogdanov, A .

MAGNETIC RESONANCE IN MEDICINE, 2004, 52 (05) :1021-1028

← 1 2 3 4 5 6 7 8 9 →